faidr Listening Experience Displays Significant Improvement with Percentage of Stations Using the Advanced AI Algorithm Increasing from 10% to 88% On Track to Apply Advanced AI to Remaining 12% of Stations by End of Q3 BOULDER, CO / ACCESSWIRE / August 1, 2022 / Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or… Read More..

EMA Guidance Provides Clear Path Forward for Quoin’s Netherton Syndrome Product in Europe ASHBURN, Va., July 28, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announces that it has received comprehensive and constructive… Read More..

PRINCETON, N.J., July 27, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received agreement from the US Food & Drug Administration… Read More..